Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows from Operating Activities
Net Loss	$ (1,676,357)	$ (933,121)
Adjustments to reconcile net loss to net cash (used) by operating activities:
Loss on Extinguishment of Debt	221,232	0
Stock based compensation	348,110	0
Acquisition of Net Assets	0	(332)
Amortization of Discount on Notes Payable	68,328	171,917
Amortization of Intangible Assets	37,024	0
(Increase) Decrease in:
Accounts Receivable	27,800	(39,364)
Inventory	(190)	(41,341)
Prepaid Expense	(9,745)	8,171
Escrow	0	1,782
Licensing Agreement	0	1,000
Increase (Decrease) in:
Accounts Payable	410,490	138,279
Accrued Liabilities	310,646	249,373
Net Cash Used By Operating Activities	(262,662)	(443,636)
Cash Flows from Investing Activities:
Cash Received in Acquisition of HereLab	0	119
Net Cash Provided By Investing Activities	0	119
Cash Flows from Financing Activities:
Cash Received from Convertible Note Payable	285,000	500,000
Net Cash Provided by Financing Activities	285,000	500,000
Net (Decrease) Increase in Cash and Cash Equivalents	22,338	56,483
Cash and Cash Equivalents at Beginning of period	39,226	60,863
Cash and Cash Equivalents at End of period	61,564	117,346
Supplemental disclosure of cash flow Information:
Interest paid during the period	19,816	213,178
Supplemental disclosure if non-cash Investing and Financing Activities:
Discount on notes payable	$ 146,300	$ 500,000